Home/ Supplements/ Omega 3/ EPA Fish Oil

EPA Fish Oil

product on market Softgel Capsule Vinsic Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Eicosapentaenoic acid (EPA) and omega-3 fatty acids are supported by strong evidence for promoting cardiovascular health and reducing systemic inflammation. Research indicates these components help maintain healthy triglyceride levels in the blood. The overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for EPA Fish Oil
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
15
Servings
Fat/Fatty Acid
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
20 Calorie(s)
Total Fat
2 Gram(s) (3% DV)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Glycerol Water, Purified
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Adults take 2 softgels 1 or 2 times daily with meals.

Warnings & Precautions

Caution: Consult physician if you are pregnant/nursing, taking medication, or have a medical condition.

Do not use if safety seal is damaged or missing.

Keep out of reach of children.

Allergen: Contains fish.

Formulation Notes

Supports heart& joint health Helps maintain healthy triglyceride levels Supports brain & skin health

Pharmaceutical-Grade EPA 99%

Additional Information

Storage: Store in a cool, dry place.

Metadata

Product Details

UPC / SKU8 50052 25977 8
DSLD Entry Date2025-07-24
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandVinsic
DSLD ID335761
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.